NLRP3 and atherosclerosis: In vivo experiments suggested that RA played a protective role in nicotine-induced atherosclerosis via inhibiting the axis of ROS-NLRP3-CRP, and therefore RA was a potentially effective treatment for atherosclerosis, especially in smokers [100].